Londinia Opportunities Analyses - 06/09/2023 (GMT) INNATE PHARMA - 1H

- EUR (-)

- 15 min delayed data - Euronext Paris

Type:	Stocks
Ticker:	IPH
ISIN:	FR0010331421

Londinia

I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.

Europe Stocks
Timeframe : 1H
- Analysis generated on
Status : TARGET REACHED

Summary of the analysis

Trends

Short term: Strongly bullish

Underlying: Strongly bullish

Technical indicators

78%

17%

My opinion

Bullish above 3.075 EUR

My targets

3.125 EUR (+0.81%)

3.264 EUR (+5.29%)

My analysis

All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on INNATE PHARMA as long as the price remains well above 3.075 EUR. The buyers' bullish objective is set at 3.125 EUR. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 3.264 EUR. If there is any crossing, the next objective would be the resistance located at 3.418 EUR. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.

In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.

Force

8.4

Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.

Additional analysis

Quotes

INNATE PHARMA rating 3.100 EUR. The price registered an increase of +1.64% on the session with the lowest point at 3.080 EUR and the highest point at 3.100 EUR. The deviation from the price is +0.65% for the low point and 0% for the high point.

3.080

3.100

A bullish opening was detected by the Central Gaps scanner. Buyers are trying to impose a bullish momentum in the very short term.

Bullish opening

Type : Bullish

Timeframe : Openning

So that you have an overall view of the price change, here is a table showing the variations over several periods:

Technical

A technical analysis in 1H of this INNATE PHARMA chart shows a strongly bullish trend. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.

An assessment of technical indicators shows a strong bullish signal.
The Central Indicators scanner specialised in technical indicators, has not detected anything further.

The analysis of the price chart with Central Patterns scanners does not return any result.

No result was found by the Central Candlesticks scanner on Japanese candlesticks.

ProTrendLines

Price

	S3	S2	S1	Price	R1	R2	R3
ProTrendLines	2.799	2.960	3.075	3.100	3.125	3.264	3.418
Change (%)	-9.71%	-4.52%	-0.81%	-	+0.81%	+5.29%	+10.26%
Change	-0.301	-0.140	-0.025	-	+0.025	+0.164	+0.318
Level	Major	Minor	Major	-	Intermediate	Minor	Minor

Attention could also be paid to pivot points to set price objectives:

Daily

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	2.767	2.863	2.957	3.053	3.147	3.243	3.337
Camarilla	2.998	3.015	3.033	3.050	3.067	3.085	3.102
Woodie	2.765	2.863	2.955	3.053	3.145	3.243	3.335
Fibonacci	2.863	2.936	2.981	3.053	3.126	3.171	3.243

Weekly

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	2.540	2.615	2.685	2.760	2.830	2.905	2.975
Camarilla	2.715	2.728	2.742	2.755	2.768	2.782	2.795
Woodie	2.538	2.614	2.683	2.759	2.828	2.904	2.973
Fibonacci	2.615	2.670	2.705	2.760	2.815	2.850	2.905

Monthly

Pivot points	S3	S2	S1	PP	R1	R2	R3
Standard	2.093	2.317	2.513	2.737	2.933	3.157	3.353
Camarilla	2.595	2.633	2.672	2.710	2.749	2.787	2.826
Woodie	2.080	2.310	2.500	2.730	2.920	3.150	3.340
Fibonacci	2.317	2.477	2.576	2.737	2.897	2.996	3.157

Numerical data

The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:

Technical indicators

Moving averages

RSI (14):	61.04
MACD (12,26,9):	0.0510
Directional Movement:	24.425
AROON (14):	42.857
DEMA (21):	3.050
Parabolic SAR (0,02-0,02-0,2):	2.950
Elder Ray (13):	0.039
Super Trend (3,10):	2.939
Zig ZAG (10):	3.050
VORTEX (21):	0.9750
Stochastique (14,3,5):	67.95
TEMA (21):	3.071
Williams %R (14):	-38.46
Chande Momentum Oscillator (20):	0.150
Repulse (5,40,3):	-0.0610
ROCnROLL:	1
TRIX (15,9):	0.2070
Courbe Coppock:	10.37

MA7:	2.836
MA20:	2.770
MA50:	2.788
MA100:	2.921
MAexp7:	3.044
MAexp20:	2.986
MAexp50:	2.913
MAexp100:	2.852
Price / MA7:	+9.31%
Price / MA20:	+11.91%
Price / MA50:	+11.19%
Price / MA100:	+6.13%
Price / MAexp7:	+1.84%
Price / MAexp20:	+3.82%
Price / MAexp50:	+6.42%
Price / MAexp100:	+8.70%

Quotes : - 15 min delayed data - Euronext Paris

News

Don't forget to follow the news on INNATE PHARMA. At the time of publication of this analysis, the latest news was as follows: